Skip to Main Content

Advertisement

Skip Nav Destination

Current Issue

September 2022


Care, Interrupted

When patient care is interrupted, ensuring clear communication and empowering the patient are key to successful hand-offs between providers.


 

Viewpoints

Editor’s Corner

Clinical Trial Design Fails Too Many Patients

Education

You Make the Call

You Make the Call: What would you advise when biopsy results show nodular lymphocyte-predominant Hodgkin lymphoma but lab and bone marrow tests are negative?

You Make the Call: Readers' Response

What would you advise when biopsy results show nodular lymphocyte-predominant Hodgkin lymphoma but lab and bone marrow tests are negative?

Practice Update

Cardiovascular Disease and Myeloproliferative Neoplasms

Demystifying the Lab

Thromboelastography: Measuring Blood Coagulation in Real Time

Spotlight

Pulling Back the Curtain

Pulling Back the Curtain: Thomas R. Chauncey, MD, PhD

Feature Articles

Care, Interrupted

News

Latest and Greatest

Umbralisib Approval for Lymphoma Indications Withdrawn
Tisagenlecleucel Approved for R/R FL
Breakthrough Therapy Designation Granted to Efanesoctocog Alfa for Hemophilia A
Azacitidine Approved for Juvenile Myelomonocytic Leukemia
HHS Extends American Rescue Plan Spending Deadline by a Year

Written in Blood

HCT and GT Show Similar Outcomes for ADA-SCID in the Contemporary Era
Prophylactic TXA Does Not Prevent Bleeding in Thrombocytopenia From Hematologic Malignancy Treatment
Comparative Analysis Shows Axi-Cel Durable Treatment Benefit in R/R FL

Blood Advances in a Different Vein

Pooled Analysis Shows Good Results With Avapritinib in Previously Treated Advanced SM
Coagulation Effects Differ in Knee Arthroscopy and Casting After Leg Injury
Tool Assesses Quality of Life for Patients With HHT
AlloHCT Outcomes Improved in Adults With ALL
Insights Into the Burden of MM on Caregivers

Literature Scan

Five-Year Follow-Up of Ruxolitinib Trial Shows Durable Clinical Results in PV Without Splenomegaly
Venetoclax Proves Active in Newly Diagnosed AML

ASH Directions

National Sickle Cell Awareness Month: Highlights of Sickle Cell Disease at ASH

Data Stream

September 2022 Data Stream

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement